DE69118978D1 - Behandlung von entzündlichen Erkrankungen mit 15-Ketoprostaglandinen - Google Patents
Behandlung von entzündlichen Erkrankungen mit 15-KetoprostaglandinenInfo
- Publication number
- DE69118978D1 DE69118978D1 DE69118978T DE69118978T DE69118978D1 DE 69118978 D1 DE69118978 D1 DE 69118978D1 DE 69118978 T DE69118978 T DE 69118978T DE 69118978 T DE69118978 T DE 69118978T DE 69118978 D1 DE69118978 D1 DE 69118978D1
- Authority
- DE
- Germany
- Prior art keywords
- treatment
- inflammatory diseases
- keto prostaglandins
- prostaglandins
- keto
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000027866 inflammatory disease Diseases 0.000 title abstract 2
- 229940094443 oxytocics prostaglandins Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18496390 | 1990-07-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69118978D1 true DE69118978D1 (de) | 1996-05-30 |
DE69118978T2 DE69118978T2 (de) | 1996-11-14 |
Family
ID=16162415
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69118978T Expired - Lifetime DE69118978T2 (de) | 1990-07-10 | 1991-07-03 | Behandlung von entzündlichen Erkrankungen mit 15-Ketoprostaglandinen |
Country Status (10)
Country | Link |
---|---|
US (1) | US5346921A (de) |
EP (1) | EP0467564B1 (de) |
JP (1) | JP2562239B2 (de) |
KR (1) | KR100195430B1 (de) |
AT (1) | ATE137116T1 (de) |
CA (1) | CA2046069C (de) |
DE (1) | DE69118978T2 (de) |
DK (1) | DK0467564T3 (de) |
ES (1) | ES2089136T3 (de) |
GR (1) | GR3019760T3 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5508302A (en) * | 1994-09-28 | 1996-04-16 | American Home Products Corporation | Phospholipase A2 inhibitors |
HU223345B1 (hu) | 1995-12-20 | 2004-08-30 | Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. | Eljárás alfa, béta-telítetlen ketonok sztereoszelektív redukciójára |
DK0857718T3 (da) * | 1996-06-10 | 2002-12-16 | Sucampo Ag | Endothelinantagonist |
CN1206997C (zh) | 1997-11-28 | 2005-06-22 | 株式会社·R-技术上野 | 内皮缩血管肽拮抗剂 |
US6486207B2 (en) | 1998-12-10 | 2002-11-26 | Nexmed (Holdings), Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
US6825234B2 (en) | 1998-12-10 | 2004-11-30 | Nexmed (Holdings) , Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
DE60010913T2 (de) | 1999-10-15 | 2005-06-09 | Sucampo Ag | Bizyklische Verbindungen, Zusammenstellung und Verfahren zu ihrer Stabilisierung |
DE60225266T2 (de) * | 2001-05-18 | 2009-03-19 | Sucampo Ag | Zusammensetzung mit induzierendem kathartischen effekt |
CA2458230A1 (en) * | 2001-08-23 | 2003-03-06 | Sucampo Ag | Method and composition for treatment of ocular hypertension and glaucoma |
AR037524A1 (es) | 2001-11-14 | 2004-11-17 | Sucampo Ag | Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion |
CA2600331C (en) * | 2005-03-04 | 2014-07-08 | Sucampo Ag | Use of 11-deoxy-prostaglandin for treating peripheral vascular diseases |
US20060281818A1 (en) * | 2005-03-21 | 2006-12-14 | Sucampo Ag, North Carolina State University | Method for treating mucosal disorders |
US20070037193A1 (en) * | 2005-08-12 | 2007-02-15 | Rong-Hwa Lin | Modulation of peroxisome proliferator-activated receptors |
US20090082442A1 (en) * | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched lubiprostone |
TW201309301A (zh) * | 2011-06-21 | 2013-03-01 | R Tech Ueno Ltd | 處置發炎性疾病、過敏性疾病以及自體免疫疾病用之醫藥組成物 |
KR102578588B1 (ko) * | 2021-07-22 | 2023-09-14 | 정찬희 | 자석이 구비된 도어 잠금장치 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2321876A1 (fr) * | 1975-08-29 | 1977-03-25 | Roussel Uclaf | Nouveaux derives cyclopentaniques, leur procede de preparation et leur application comme medicaments |
US4097603A (en) * | 1977-09-06 | 1978-06-27 | The Upjohn Company | Gastric cytoprotection with non-antisecretory doses of prostaglandins |
NL8105635A (nl) * | 1981-12-15 | 1983-07-01 | Univ Erasmus | Geneesmiddel met transplantaatafstotings- en/of immunologische ontstekingsremmende werking, alsmede werkwijze voor de remming van transplantaatafstoting en/of immunologische ontsteking. |
JPS59134746A (ja) * | 1982-11-05 | 1984-08-02 | ザ,プロクタ−,エンド,ギヤンブル,カンパニ− | 新規プロスタグランジン類似体 |
EP0153858A3 (de) * | 1984-02-29 | 1985-12-11 | The Upjohn Company | Therapeutische Anwendung von Protaglandinen |
US4612330A (en) * | 1985-02-04 | 1986-09-16 | Eli Lilly And Company | Antiinflammatory method |
GB8625325D0 (en) * | 1986-10-22 | 1986-11-26 | Glaxo Group Ltd | Chemical compounds |
CA1323364C (en) * | 1987-01-28 | 1993-10-19 | Ryuzo Ueno | Prostaglandins e and anti ulcer agents containing same |
CA1322749C (en) * | 1987-01-28 | 1993-10-05 | Ryuzo Ueno | Prostaglandins of the d series, and tranquilizers and soporifics containing the same |
CA1324129C (en) * | 1987-04-30 | 1993-11-09 | Ryuzo Ueno | Prostaglandins of the f series |
ES2038289T3 (es) * | 1987-05-15 | 1993-07-16 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Utilizacion de 15-ceto-pges para la fabricacion de un medicamento para aumentar la temperatura corporal. |
ATE108330T1 (de) * | 1987-09-18 | 1994-07-15 | R Tech Ueno Ltd | Hypotensive okulare mittel. |
GB2210556B (en) * | 1987-10-02 | 1991-07-17 | Ueno Seiyaku Oyo Kenkyujo Kk | The use of 15-keto-16-halo-prostaglandins in cathartic compositions |
JP2597629B2 (ja) * | 1988-02-26 | 1997-04-09 | 株式会社 上野製薬応用研究所 | 13,14−ジヒドロ−15−ケトプロスタグランジン類の安定化 |
AU616502B2 (en) * | 1988-04-22 | 1991-10-31 | Medvet Science Pty. Ltd. | Treatment of inflammatory disorders in humans |
JP2597649B2 (ja) * | 1988-05-11 | 1997-04-09 | 株式会社上野製薬応用研究所 | 気管・気管支拡張剤 |
AU619543B2 (en) * | 1988-05-11 | 1992-01-30 | Sucampo Ag | Use of 15-ketoprostaglandin e or f compounds for uterine contraction |
ES2055051T3 (es) * | 1988-05-23 | 1994-08-16 | Ueno Seiyaku Oyo Kenkyujo Kk | Un metodo para la fabricacion de un medicamento eficaz para aumentar la presion sanguinea. |
JP2515442B2 (ja) * | 1990-05-01 | 1996-07-10 | 株式会社上野製薬応用研究所 | 膵臓疾患処置剤 |
-
1991
- 1991-07-02 CA CA002046069A patent/CA2046069C/en not_active Expired - Lifetime
- 1991-07-03 AT AT91306069T patent/ATE137116T1/de not_active IP Right Cessation
- 1991-07-03 ES ES91306069T patent/ES2089136T3/es not_active Expired - Lifetime
- 1991-07-03 EP EP91306069A patent/EP0467564B1/de not_active Expired - Lifetime
- 1991-07-03 DK DK91306069.5T patent/DK0467564T3/da active
- 1991-07-03 DE DE69118978T patent/DE69118978T2/de not_active Expired - Lifetime
- 1991-07-10 JP JP3169731A patent/JP2562239B2/ja not_active Expired - Lifetime
- 1991-07-10 KR KR1019910011731A patent/KR100195430B1/ko not_active IP Right Cessation
-
1992
- 1992-11-05 US US07/972,092 patent/US5346921A/en not_active Expired - Lifetime
-
1996
- 1996-04-25 GR GR960400861T patent/GR3019760T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP2562239B2 (ja) | 1996-12-11 |
KR100195430B1 (ko) | 1999-06-15 |
EP0467564B1 (de) | 1996-04-24 |
ATE137116T1 (de) | 1996-05-15 |
GR3019760T3 (en) | 1996-07-31 |
DE69118978T2 (de) | 1996-11-14 |
ES2089136T3 (es) | 1996-10-01 |
CA2046069A1 (en) | 1992-01-11 |
KR920002151A (ko) | 1992-02-28 |
EP0467564A2 (de) | 1992-01-22 |
DK0467564T3 (da) | 1996-05-13 |
JPH0532551A (ja) | 1993-02-09 |
US5346921A (en) | 1994-09-13 |
EP0467564A3 (en) | 1992-07-08 |
CA2046069C (en) | 2002-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE169219T1 (de) | Behandlung von katarakt mit 15-keto- prostaglandinderivaten | |
ATE82121T1 (de) | Arzneimittel fuer die therapeutische behandlung von alopezie. | |
DE69118978D1 (de) | Behandlung von entzündlichen Erkrankungen mit 15-Ketoprostaglandinen | |
ATE143263T1 (de) | Behandlung von neurodegenerativen erkrankungen | |
DK0435443T3 (da) | Anvendelse af en 15-ketoprostaglandinforbindelse til forbedring af den encephaliske funktion | |
DE69213057D1 (de) | Stimulierung von Wundheilung mit 15-Keto-prostaglandinverbindungen | |
ATE174221T1 (de) | Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten | |
DE69024744D1 (de) | Behandlung der hepatobilären Erkrankung mit 15-Ketoprostaglandin-Derivaten | |
DE69032000D1 (de) | Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten | |
ATE129895T1 (de) | Behandlung von pulmonarer disfunktion mit 15-keto-prostaglandin-derivaten. | |
ATE146964T1 (de) | Behandlung von katarakt mit prostacyclinverbindungen | |
DE69124415D1 (de) | Verwendung von 15-Dehydroxy-16-Oxoprostaglandin bei der Behandlung von allergischen Erkrankungen | |
DK0458537T3 (da) | Anvendelse af en terapeutisk forbindelse til behandling af bronkitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: SUCAMPO AG, ZUG, CH |